SecBot SecBot

XTNT

Xtant Medical Holdings, Inc.
NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001453593 Healthcare & Medical Devices
$0.2751 −0.00 (−1.75%)
Oct 26 4:00 PM ET · prev $0.2800
Market cap
$43.8M
Nano cap
Consensus
Buy
89% Buy or better · 9 analysts
Median target
$1.00
+264% · range $0.6000–1.50
Next earnings
Nov 6
in 11 days · EPS est. −$0.02
1 year
−68.7%
from $0.8800 · Oct 27
30 days
−23.6%
from $0.3600
52-week range
$0.2751–0.9200
at the low
Avg volume 20D
119.1K
Sep 30 spike 355.4K
Short interest
143.6K
≈0.1% of shares · −46.6%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 6, 2026
Strongest BEARISH Xtant Medical reported Q2 2026 revenue of $23.0M, a 35% YoY decline from $35.4M, and a net loss of $9.4M vs…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 1 trimmed or exited.

  • AnalystsBULLISH

    8 of 9 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.010 → −$0.023 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersCOVERING

    Short interest −46.6% to 143.6K shares. 1.0 days to cover, ≈0.1% of shares.

  • TrendDOWNTREND

    18% below its 50-day average. New closing low $0.2751 on Oct 26.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
MILLENNIUM MANAGEMENT LLCTRIM84,490$35.6K
MILLENNIUM MANAGEMENT LLCTRIM132,354$73.9K
NORTHERN TRUST CORPADD99,598$55.6K
JANE STREET GROUP, LLCADD33,978$19.0K
RENAISSANCE TECHNOLOGIES LLCADD919,860$721.2K
Private Advisor Group, LLCTRIM85,000$66.6K
Equitable Holdings, Inc.TRIM11,450$9.0K
UBS Group AGNEAR_EXIT8$6.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 89% rate it Buy or better
Strong Buy2Buy6Hold1Sell0Strong Sell0
12-month targets · 3 analysts

Price is below the lowest target. Median implies +264%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Sep 2, 2026LUCID CAPITAL MARKETS
INITIATE
INITIATEBuy
May 13, 2026BTIG
REITERATE
REITERATEBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Aug 15, 2026
Neils Scott C
CFO and Assistant Secretary
TAX W/H$8.7K
Aug 15, 2026
Neils Scott C
CFO and Assistant Secretary
AWARD400,000 sh
Aug 15, 2026
Browne Sean E
President and CEO
AWARD550,000 sh
Aug 15, 2026
Browne Sean E
President and CEO
TAX W/H$3.3K
Aug 15, 2026
Schallenberger Mark A.
Chief Operating Officer
AWARD450,000 sh
Aug 15, 2026
Schallenberger Mark A.
Chief Operating Officer
TAX W/H$2.2K
Aug 15, 2026
Vizirgianakis Stavros G.
Director
AWARD323,275 sh
Aug 15, 2026
JAIN ABHINAV
Director
AWARD215,517 sh

Earnings setup

Estimates
Nov 6
reports in 11 days
−$0.02
EPS estimate, this quarter
−133%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.02-$0.03–-$0.02-133.3%$25.5M
Next Q-$0.00-$0.01–$0.00+33.4%$30.1M
Current FY-$0.08-$0.08–-$0.08+0.0%$99.4M
Next FY-$0.03-$0.06–-$0.01-500.0%$110.2M

Short side

FINRA· Sep 30, 2026
143,564
shares short
-46.6%
vs prior settlement
1.0
days to cover
≈0.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 15, 2026 Insider
Neils Scott C surrendered for taxes 28,155 shares
CFO and Assistant Secretary @ $0.3100 ($8.7K)
Aug 15, 2026 Insider
Neils Scott C was granted 400,000 shares
CFO and Assistant Secretary
Aug 15, 2026 Insider
Browne Sean E was granted 550,000 shares
President and CEO
Aug 11, 2026 SEC
Xtant Medical reported Q2 2026 revenue of $23.0M, a 35% YoY decline from $35.4M, and a net loss of $9.4M vs net income…
8-K — Impact 6/10
Aug 11, 2026 Earnings calendar
XTNT Q2 2026 Earnings Scheduled — 2026-08-11
Jun 30, 2026 Inst.
MILLENNIUM MANAGEMENT LLC — TRIM
84,490 shares ($35.6K)
Apr 13, 2026 SEC
Xtant Medical signed an exclusive U.S. distribution agreement for Dilon's HEMOBLAST Bellows product, hiring 20 sales…
8-K — Impact 6/10
Mar 31, 2026 SEC
Xtant Medical reported full-year 2025 revenue of $133.9 million, a 14% year-over-year increase, and achieved…
8-K — Impact 7/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 6, 2026
Earnings date
XTNT Q3 2026 Earnings Scheduled — 2026-11-06
Recent
Aug 11, 2026
Earnings date
XTNT Q2 2026 Earnings Scheduled — 2026-08-11
Aug 6, 2026
Earnings
Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026
BELGRADE, Mont., Aug. 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical…
Aug 4, 2026
Press release
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference
BELGRADE, Mont., Aug. 4, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical…
Jul 30, 2026
Earnings date
XTNT Q2 2026 Earnings Scheduled — 2026-07-30
May 13, 2026
Earnings date
XTNT Q1 2026 Earnings Scheduled — 2026-05-13

SecBot reports

3 filings · 0 bullish · 1 bearish · 2 mixed
All XTNT filing & press-release reports (3)